Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2016

01-11-2016 | Editorial

Diagnostic Delay in Crohn’s Disease: Time for Red Flags

Authors: Gionata Fiorino, Silvio Danese

Published in: Digestive Diseases and Sciences | Issue 11/2016

Login to get access

Excerpt

The time between the initial manifestation of a disease and its correct diagnosis is termed diagnostic delay . The significance of diagnostic delay is that the postponement of the institution of effective treatment can profoundly affect patient well-being and overall disease evolution. The diagnosis of Crohn’s disease (CD) is often delayed 5–9 months due to the variability and subtlety of its initial manifestations, as opposed to ulcerative colitis (UC), which due to its consistent initial symptoms and manifestations is usually diagnosed more rapidly [1, 2]. Moreover, CD patients with pure ileal disease and age <40 at diagnosis are significantly at risk of considerable diagnostic delay (>24 months) [1], data confirmed by the results of the IMPACT survey among European patients. In this large online survey promoted by the European Federation of Crohn’s and Colitis Associations (EFCCA) involving 4990 patients with inflammatory bowel disease (IBD), 20 % of subjects had to wait up to 5 years after symptomatic disease onset in order to receive the correct diagnosis of CD, with consequent impairment of their quality of life [3]. …
Literature
1.
go back to reference Vavricka SR, Spigaglia SM, Rogler G, et al. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:496–505.CrossRefPubMed Vavricka SR, Spigaglia SM, Rogler G, et al. Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:496–505.CrossRefPubMed
2.
go back to reference Nahon S, Lahmek P, Lesgourgues B, et al. Diagnostic delay in a French cohort of Crohn’s disease patients. J Crohns Colitis. 2014;8:964–969.CrossRefPubMed Nahon S, Lahmek P, Lesgourgues B, et al. Diagnostic delay in a French cohort of Crohn’s disease patients. J Crohns Colitis. 2014;8:964–969.CrossRefPubMed
3.
go back to reference Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007;1:10–20.CrossRefPubMed Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: results of the European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis. 2007;1:10–20.CrossRefPubMed
4.
go back to reference Schoepfer AM, Dehlavi MA, Fournier Net al. Diagnostic delay in Crohn’s disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013;108:1744–1753; quiz 1754. Schoepfer AM, Dehlavi MA, Fournier Net al. Diagnostic delay in Crohn’s disease is associated with a complicated disease course and increased operation rate. Am J Gastroenterol. 2013;108:1744–1753; quiz 1754.
5.
go back to reference Pellino G, Sciaudone G, Selvaggi F, Riegler G. Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in Southern Italy. Eur J Gastroenterol Hepatol. 2015;27:175–181.CrossRefPubMed Pellino G, Sciaudone G, Selvaggi F, Riegler G. Delayed diagnosis is influenced by the clinical pattern of Crohn’s disease and affects treatment outcomes and quality of life in the long term: a cross-sectional study of 361 patients in Southern Italy. Eur J Gastroenterol Hepatol. 2015;27:175–181.CrossRefPubMed
6.
go back to reference Li Y, Ren J, Wang G, et al. Diagnostic delay in Crohn’s disease is associated with increased rate of abdominal surgery: a retrospective study in Chinese patients. Dig Liver Dis. 2015;47:544–548.CrossRefPubMed Li Y, Ren J, Wang G, et al. Diagnostic delay in Crohn’s disease is associated with increased rate of abdominal surgery: a retrospective study in Chinese patients. Dig Liver Dis. 2015;47:544–548.CrossRefPubMed
7.
go back to reference Pariente B, Mary JY, Danese S, et al. Development of the Lemann index to assess digestive tract damage in patients with Crohn’s disease. Gastroenterology. 2015;148:e53.CrossRef Pariente B, Mary JY, Danese S, et al. Development of the Lemann index to assess digestive tract damage in patients with Crohn’s disease. Gastroenterology. 2015;148:e53.CrossRef
8.
go back to reference Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–1155.CrossRefPubMedPubMedCentral Thia KT, Sandborn WJ, Harmsen WS, Zinsmeister AR, Loftus EV Jr. Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort. Gastroenterology. 2010;139:1147–1155.CrossRefPubMedPubMedCentral
9.
go back to reference Nahon, S, Lahmek, P, Paupard, T, Lesgourgues, B, Chaussade, S, Peyrin-Biroulet, L, Abitbol, V. Diagnostic delay is associated with a greater risk of early surgery in a french cohort of Crohn’s disease patients. Dig Dis Sci. (Epub ahead of print). doi:10.1007/s10620-016-4189-z. Nahon, S, Lahmek, P, Paupard, T, Lesgourgues, B, Chaussade, S, Peyrin-Biroulet, L, Abitbol, V. Diagnostic delay is associated with a greater risk of early surgery in a french cohort of Crohn’s disease patients. Dig Dis Sci. (Epub ahead of print). doi:10.​1007/​s10620-016-4189-z.
10.
go back to reference Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut. 2010;59:141–147.CrossRefPubMed Peyrin-Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. Early Crohn disease: a proposed definition for use in disease-modification trials. Gut. 2010;59:141–147.CrossRefPubMed
11.
go back to reference Danese S, Fiorino G, Fernandes C, Peyrin-Biroulet L. Catching the therapeutic window of opportunity in early Crohn’s disease. Curr Drug Targets. 2014;15:1056–1063.CrossRefPubMed Danese S, Fiorino G, Fernandes C, Peyrin-Biroulet L. Catching the therapeutic window of opportunity in early Crohn’s disease. Curr Drug Targets. 2014;15:1056–1063.CrossRefPubMed
12.
go back to reference Khanna R, Bressler B, Levesque BG, et al. Early combined immunosuppression for the management of Crohn’s disease (REACT): a cluster randomised controlled trial. Lancet. 2015;386:1825–1834.CrossRefPubMed Khanna R, Bressler B, Levesque BG, et al. Early combined immunosuppression for the management of Crohn’s disease (REACT): a cluster randomised controlled trial. Lancet. 2015;386:1825–1834.CrossRefPubMed
13.
go back to reference D’Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet. 2008;371:660–667.CrossRefPubMed D’Haens G, Baert F, van Assche G, et al. Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn’s disease: an open randomised trial. Lancet. 2008;371:660–667.CrossRefPubMed
14.
go back to reference Danese S, Fiorino G, Mary JY, et al. Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative. J Crohns Colitis. 2015;9:601–606.CrossRefPubMed Danese S, Fiorino G, Mary JY, et al. Development of red flags index for early referral of adults with symptoms and signs suggestive of Crohn’s disease: an IOIBD initiative. J Crohns Colitis. 2015;9:601–606.CrossRefPubMed
Metadata
Title
Diagnostic Delay in Crohn’s Disease: Time for Red Flags
Authors
Gionata Fiorino
Silvio Danese
Publication date
01-11-2016
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2016
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-016-4298-8

Other articles of this Issue 11/2016

Digestive Diseases and Sciences 11/2016 Go to the issue

Fellows and Young Gis Section

Training in Gastrointestinal Motility

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.